Telephone
64.9.276.2690
Address
Unit 107 23 Edwin Street Mount Eden, Auckland 1024
Description
Algorae Pharmaceuticals Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Mount Eden, New Zealand.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.02
Trade Value (12mth)
AU$3,272.00
1 week
8.33%
1 month
0%
YTD
9.69%
1 year
-22.57%
All time high
0.58513
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
-$2m
Free Cash Flow Return
-51.00%
ROIC
-54.10%
Interest Coverage
N/A
Quick Ratio
9.40
Shares on Issue (Fully Dilluted)
1461m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
CSIRO Grant for Artificial Intelligence Platform
×
CSIRO Grant for Artificial Intelligence Platform |
28 September 23 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
27 October 23 |
Quarterly Activities/Appendix 5B Cash Flow Report
×
Quarterly Activities/Appendix 5B Cash Flow Report |
25 October 23 |
1AI develops Artificial Intelligence Platform
×
1AI develops Artificial Intelligence Platform |
24 October 23 |
Corporate Governance Statement
×
Corporate Governance Statement |
23 November 23 |
1AI commences AI-168 pre-clinical studies
×
1AI commences AI-168 pre-clinical studies |
21 November 23 |
Addendum to September Quarterly Report
×
Addendum to September Quarterly Report |
17 October 23 |
Cleansing Statement
×
Cleansing Statement |
16 October 23 |
Proposed issue of securities - 1AI
×
Proposed issue of securities - 1AI |
16 October 23 |
Change of Director's Interest Notice x2
×
Change of Director's Interest Notice x2 |
12 September 23 |
2023 Annual General Meeting Date
×
2023 Annual General Meeting Date |
12 September 23 |
Appendix 4G
×
Appendix 4G |
11 September 23 |
MOU with UNSW to develop AI Platform
×
MOU with UNSW to develop AI Platform |
10 November 23 |
Appendix 3y and Amended Cleansing Statement
×
Appendix 3y and Amended Cleansing Statement |
10 November 23 |
Application for quotation of securities - 1AI
×
Application for quotation of securities - 1AI |
10 November 23 |
Appendix 3Y x 3 and Cleansing Statement
×
Appendix 3Y x 3 and Cleansing Statement |
08 November 23 |
Application for quotation of securities - 1AI
×
Application for quotation of securities - 1AI |
08 November 23 |
Proposed issue of securities - 1AI
×
Proposed issue of securities - 1AI |
08 November 23 |
Notification regarding unquoted securities - 1AI
×
Notification regarding unquoted securities - 1AI |
08 November 23 |
Cleansing Statement
×
Cleansing Statement |
07 November 23 |
Proposed issue of securities - 1AI
×
Proposed issue of securities - 1AI |
02 November 23 |
AGM Chairman Address to Shareholders
×
AGM Chairman Address to Shareholders |
02 November 23 |
Results of Meeting
×
Results of Meeting |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.